Related Content
Download content relating to this event and topic.
No items found.
CGT Manufacturing DACH 2027
#CGTDACH2027
ENHANCING SPEED & QUALITY IN CELL & GENE THERAPY MANUFACTURING FOR THE DACH REGION
The €1 Billion Opportunity: Scaling the Future of Cure
Munich
17
February
-
18
February
2027
00
Days
00
Hours
00
Mins
00
Secs
500
+
Attendees
Maximum Attendees
200
+
Companies
60
+
Speakers
+
Networking Hours
+
Case Studies
11
Interactive Sessions
About the Event
The DACH region has the science, the talent and the infrastructure to lead cell and gene therapy manufacturing, but scale-up is where progress is stalling. Viral vector and cell processing facilities are running above 90% utilisation, and EU ATMP frameworks add a layer of regulatory complexity that most manufacturing teams are still working through.
CGT Manufacturing DACH 2027 is the region's only conference dedicated exclusively to manufacturing execution rather than early-stage science. It brings together the operators, regulators and technology partners working through the practical bottlenecks: process transfer, automation, biosafety and supply continuity, as therapies move from clinical to commercial supply.
Across two days in Munich, the programme focuses on what it actually takes to manufacture advanced therapies at scale: safely, compliantly, and cost-effectively enough to reach patients.
Why DACH Needs This Conference
To transform the region’s CGT potential into scalable success
DACH has the science, the talent, and the infrastructure, but cell and gene therapy manufacturing is reaching a breaking point.
This is why we are hosting #CGTDACH2027:
- Capacity Shortage: Viral vector and cell processing facilities are running above 90% utilisation
- Regulatory Complexity: EU ATMP frameworks require specialised, region-specific navigation
- Cost Pressure: Manufacturing costs of €100–500K per patient are testing long-term sustainability
- Technology Transition: The shift from open to closed systems, and manual to automated processes, is reshaping how therapies are made
- Market Inflection Point: Multiple therapies are approaching commercialisation, making scalable, compliant manufacturing essential
Cell and gene therapy is the future of medicine, but only if manufacturing can keep pace. CGT Manufacturing DACH 2027 is where that work gets done.
Co-Located Events
Visit the event page to view more content.
Awards Cerermony
Visit the awards page to view more content.
Agenda at a Glance
View the Key Themes for
CGT Manufacturing DACH 2027
Commercial & Manufacturing Scale-Up
- Scaling viral vector and cell therapy manufacturing for commercial readiness
- Bridging the gap between small-scale development and industrial production
- Building sustainable CGT business models from clinical supply to commercial viability
Cell Therapy Manufacturing Industrialisation
- Scaling non-viral T-cell engineering from process development to GMP
- Maintaining editing efficiency, viability and cell quality at scale
- Overcoming manufacturing bottlenecks in autologous CAR-T production
Viral Vector Manufacturing Optimisation
- Addressing scale-up challenges in lentiviral and AAV production
- Managing process variability between R&D and GMP environments
- Improving yield, consistency and cost efficiency at scale
Tech Transfer & GMP Scale-Up
- Why CGT tech transfer fails, from R&D to GMP reality
- Manufacturing strategies across CD34 stem cell, T-cell and NK-cell platforms
- Hidden failure points emerging only during GMP execution
Quality, Biosafety & Supply Chain Readiness
- Shifting from end-point release to continuous quality control
- Strengthening biosafety controls without slowing development
- Managing critical material shortages: viral vectors, plasmids and raw materials
Ready to attend?
Register today to secure your ticket.
Speakers
Esteemed Voices From the Industry
Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.
Volker Derdau
Sanofi
Head Center of Excellence Isotope Chemistry, Senior Distinguished Scientist
Germany
Connect on LinkedInAdvisory Board Commitee
Chairman
Volker Derdau
Head Center of Excellence Isotope Chemistry, Senior Distinguished Scientist
Sanofi
Germany
Baerbel Grossmann
Sanofi
Associate Director Global Regulatory Affairs CMC Biologics
Germany
Connect on LinkedInAdvisory Board Commitee
Chairman
Baerbel Grossmann
Associate Director Global Regulatory Affairs CMC Biologics
Sanofi
Germany
Daniel Hurni
Roche
Supply Chain Enterprise Capability Lead
Switzerland
20+ years driving operational transformation in pharma/biotech, optimising E2E processes (S&OP, network design, product launch) through data integration, digital tools, and cross-functional collaboration. Proven success in change management, cost reduction, supplier management, tech transfer leader for drug product (aseptic processes), and M&A integration within complex matrix environments. Focused on building scalable, patient-centric supply chains. Adept at balancing functional priorities with enterprise strategy while influencing stakeholders at all levels. Passionate about leveraging AI and advanced analytics to enhance decision-making and operational agility. Let’s connect to discuss the future of intelligent pharma operations.
Advisory Board Commitee
Chairman
Daniel Hurni
Supply Chain Enterprise Capability Lead
Roche
Switzerland
Advisory Board Commitee
Chairman
Dr Ulrich Rümenapp
Senior Biotech Program Lead
Bayer
Germany
Advisory Board Commitee
Chairman
Marion Hitchcock
Managing Director Gene & Cell Therapies Incubator
Bayer
Germany
Advisory Board Commitee
Chairman
Hagen Cramer
Chief Technology Officer
QurAlis
USA
Chris Baldwin
Resolution Therapeutics
Vice President, Manufacturing and Supply
United Kingdom
Connect on LinkedInAdvisory Board Commitee
Chairman
Chris Baldwin
Vice President, Manufacturing and Supply
Resolution Therapeutics
United Kingdom
Advisory Board Commitee
Chairman
Dr Cecile Brocard
Head of Downstream Development
Boehringer Ingelheim
Austria
Bettina Knapp
Boehringer Ingelheim Pharma
Head of Digital Operations Drug Substance
Germany
Connect on LinkedInAdvisory Board Commitee
Chairman
Bettina Knapp
Head of Digital Operations Drug Substance
Boehringer Ingelheim Pharma
Germany
Alessio Epifanio
Johnson & Johnson Innovative Medicine
Director, Environmental Health, Safety & Sustainability
Italy
Connect on LinkedInAdvisory Board Commitee
Chairman
Alessio Epifanio
Director, Environmental Health, Safety & Sustainability
Johnson & Johnson Innovative Medicine
Italy
Gulbengu Kuzgun Yuksel
Roche
Network Head of Quality Cell & Gene Therapy
Switzerland
Connect on LinkedInAdvisory Board Commitee
Chairman
Gulbengu Kuzgun Yuksel
Network Head of Quality Cell & Gene Therapy
Roche
Switzerland
Advisory Board Commitee
Chairman
Nicoletta Loggia
CTO
Orchard TX
Switzerland
Want to Speak at This Event?
Join the roster of esteemed colleagues to discuss what you or your company are bringing to the biopharmaceutical industry.
Apply to SpeakPrincipal
No items found.
Platinum
No items found.
Gold
Silver
No items found.
Bronze
No items found.
Exhibition & Showcase
No items found.
Associate
No items found.
Media & Publicity
No items found.
Trusted by Industry Leaders
"Thanks for putting this together! I enjoyed the discussions, atmosphere and engagement of participants. Great to be there."
Takeda, Spain
Alvaro Avivar-Valderas | Associate Director - Cell Therapy Technology & Product Engine
"I thoroughly enjoyed attending the CGT Manufacturing DACH 2026 by IMAPAC. The program featured exceptionally industry-relevant talks that provided deep insights into the current landscape. Beyond the sessions, the networking opportunities were top-tier, thanks to the high caliber of participants."
Roche, Switzerland
Steffen Schulze | Strategic Analytics & Business Analytics Lead
"A fantastic deep dive into the DACH region’s CGT landscape. This conference made one thing clear: efficacy is proven, but industrialization is the new frontier. To truly move the needle, we must look beyond the lab and focus on scaling automation, streamlining supply chains, and tackling COGS. The diversity of voices - from large corporations, to tech suppliers and academic pioneers - provided a 360-degree view of the manufacturing challenges we must solve together."
FHNW, Switzerland
Dr Thomas Villiger | Professor of Bioprocess Technology
"Thanks for the invite to speak at the event. It was a really enjoyable meeting and a great opportunity to present our work to the community. Identifying key partners for ImmunoKey’s development plan is a critical aspect of getting our therapies to patients; the CGT and Biologics Manufacturing DACH meeting offered us the opportunity to engage with key CDMOs who can help us achieve this goal."
Immunokey, UK
John Bridgeman | CSO
"The Biologics and CGT Manufacturing DACH conference 2026 was very well planned and coordinated. It provided high-quality talks for staying up-to-date in our industry and I specifically enjoyed the time for networking."
Bayer, Germany
Dr Heiner Apeler | VP Head of Biologics Development
"Just back from an incredible time at the Biologics Manufacturing DACH congress! I have to be honest - as someone in Procurement, some of the deep-dives into Cell & Gene and biologics development were definitely above my scientific capabilities! However, the exchange of knowledge was fantastic, and it was a privilege to learn from such brilliant minds."
BMS, Swtzerland
Dennis Stelljes | Associate Director, Strategic Sourcing & Procurement, Biologics External Manufacturing
"Thanks for putting this together! I enjoyed the discussions, atmosphere and engagement of participants. Great to be there."
Takeda, Spain
Alvaro Avivar-Valderas | Associate Director - Cell Therapy Technology & Product Engine
"I thoroughly enjoyed attending the CGT Manufacturing DACH 2026 by IMAPAC. The program featured exceptionally industry-relevant talks that provided deep insights into the current landscape. Beyond the sessions, the networking opportunities were top-tier, thanks to the high caliber of participants."
Roche, Switzerland
Steffen Schulze | Strategic Analytics & Business Analytics Lead
Registration
Select the relevant ticket for your organisation.
*Delegate tickets must be purchased under the correct classification.
Biopharma tickets are strictly reserved for professionals employed by pharmaceutical or biopharmaceutical companies that develop, own, or commercialise therapeutic drug products, including organisations with an internal drug pipeline spanning discovery, development, clinical, or commercial stages. This category applies to companies whose primary business is the development or manufacture of drug products, not the provision of enabling technologies, equipment, platforms, or services.
Service, Solution, and Technology Provider tickets apply to all organisations offering services, platforms, technologies, equipment, consultancy, manufacturing services, or commercial solutions to the pharma and biopharma industry. This includes, but is not limited to, CROs, CDMOs, technology and equipment vendors, consultants, suppliers, and solution providers, regardless of scientific or technical focus.
Important Notice
All registrations are reviewed to ensure correct classification. Purchasing an incorrect ticket does not guarantee entry to the event. IMAPAC retains full discretion to deny access, reclassify registrations, and issue an invoice for the price difference required for correct attendance. Incorrect ticket purchases made under an inappropriate classification are not eligible for refunds under any circumstances, including where the registrant chooses not to upgrade or attend.
Registration
Register Your Interest
Be the first in line!
Register your interest to get access to tickets as soon as they go live.
Want to Sponsor This Event?
Contact the IMAPAC to learn about our sponsorship process, rates and more.
Pre Conference Workshops & Other Sessions
Visit the event page to view more content.
No items found.
Frequently Asked Questions
How can I stay updated on event details and announcements?
To stay informed about event updates, including date, venue, and agenda, please subscribe to our our official social media channels for real-time updates and announcements.
What can I expect to learn and explore during the event?
The conference will provide a comprehensive learning experience covering various aspects of the dynamic biopharmaceutical industry, ensuring attendees gain valuable insights and knowledge.
What safety measures will be in place to ensure the safety of attendees?
We are committed to ensuring the safety and well-being of all attendees. We will implement rigorous safety measures in line with local health guidelines and regulations. Specific safety measures will be communicated closer to the event date to ensure they align with the most up-to-date health recommendations. Rest assured, your safety is our priority.
Can I submit a presentation to be a speaker at this event?
We welcome presentation submissions. If you’re interested in speaking at the event, please visit this page on our website for submission guidelines and deadlines.
What type of professionals benefit most from attending?
Our event is designed to cater to a wide range of professionals within the biopharmaceutical industry, including researchers, scientists, executives, regulatory experts, and professionals involved in drug development and manufacturing.
What advantages does this conference offer participants?
Participants can expect to gain insights from industry experts, network with peers, and stay up-to-date with the latest trends and innovations in biopharmaceuticals
Are there networking opportunities or special events planned?
Yes, we have networking sessions, workshops, and social events scheduled throughout the event to facilitate connections and collaborations among attendees.
Are there sponsorship opportunities for this event?
Yes, we offer sponsorship and exhibition opportunities for businesses and organisations.
How can I register for the event?
To register for the event, you'll find multiple "register" buttons on this page to get started. You’ll find detailed instructions and options for registration, including pricing and deadlines.
Be a Part of This Event!
Don't miss out on unique networking, speaking and sponsorship opportunities.
